Dapaglyn S 5mg/50mg Tablet

Dapaglyn S 5mg/50mg Tablet contains the active components dapagliflozin and sitagliptin, two medications used to treat type 2 diabetes mellitus. They operate through different mechanisms and may be combined to help control blood sugar levels in certain patients. Dapagliflozin belongs to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors and works by lowering blood glucose levels and reducing overall blood sugar burden in the body. Sitagliptin is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It regulates blood glucose levels by stimulating insulin release and reducing glucagon production, a hormone that raises blood sugar. This medication can be particularly beneficial for overweight or obese patients with type 2 diabetes, as it may help achieve and maintain a healthy body weight. It is indicated for treating type 2 diabetes only and should not be used to treat type 1 diabetes. Patients with known hypersensitivity or allergy to dapagliflozin, sitagliptin, or other components of this medication should not take it. The medication is primarily eliminated through the kidneys. Therefore, patients with severe renal impairment or end-stage renal disease should not use this medication. During periods of illness, surgery, or other stressful situations, there may be an increased risk of developing ketoacidosis, particularly in those taking dapagliflozin. Temporary discontinuation of this medication during such events may be necessary. Limited data exist on the safety of Dapaglyn S 5mg/50mg Tablet during pregnancy and breastfeeding. Pregnant or breastfeeding patients should consult their healthcare provider before using this medication.

The Dapaglyn S 5mg/50mg Tablet in the treatment of type 2 diabetes provides a dual therapeutic effect by lowering blood glucose levels through different mechanisms: dapagliflozin reduces glucose reabsorption in the kidneys, leading to increased urinary excretion, while sitagliptin enhances insulin secretion and reduces glucagon production. This approach improves glycemic control, reduces the risk of hypoglycemia, and may offer cardiovascular and renal benefits.

Dapaglyn S 5mg/50mg Tablet can be administered orally in tablet form. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider.

Dapaglyn S 5mg/50mg Tablet cause some side effects like all medications, although not everyone will experience them. Serious Upper respiratory tract infections (colds, sore throat) Headache Stomach upset or nausea Diarrhea Hypoglycemia (low blood sugar) Joint pain (arthralgia) Common Genital yeast infections (vaginal or penile) Urinary tract infections (UTIs) Increased urination Thirst Dehydration Low blood pressure (hypotension) Dizziness or lightheadedness Increased levels of cholesterol and blood fats (hyperlipidemia)

Take Dapaglyn S 5mg/50mg Tablet exactly as prescribed by your doctor for type 2 diabetes. Watch for infections in the genital or urinary area, and stay well-hydrated to avoid dehydration. Be aware of diabetic ketoacidosis symptoms like nausea, vomiting, or abdominal pain, and seek help if they appear. If you have kidney issues or are combining it with other diabetes medications, monitor for side effects carefully. Attend follow-up appointments regularly and discuss any concerns with your healthcare provider.